SURPASS-3 extension data: what happens after the trial stops
A design note rather than a result: what the comparator was, and what that permits you to conclude.
November 2024 — Vol. 1, No. 11
Page 4 of 4 of this archive, newest first.
Also filed — page 4
the rolling newsroom, November 2024Sweden caps tirzepatide prescribing to 16 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
What changed at WXT in November, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
A supplier suspends shipping to New Zealand after 14 consecutive customs detentions
The route did not close because of a rule about peptides.
Sweden declines to reimburse liraglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
Xianning export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
What the new Brazil guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
From the floor in Shanghai: 18 posters, one theme
Reported from the sessions, and from the two hours afterwards.
Hong Kong export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
Independent analysis puts a SGN exenatide lot at 96.4%, against 94.7% on the certificate
The report states the gradient, the wavelength and the integration threshold, which is more than most.
Switzerland pharmacy body issues counselling standards for exenatide initiation
The evidence base is thin and the document says so, which is to its credit.
The quiet end of the consolidator trading as Meridian Freight Partners
A proper account of an operation that existed, and of what closing it cost.
What changed at WWB in November, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Argentina caps exenatide prescribing to 16 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
Inspectors cite the consolidator trading as Meridian Freight Partners over sterility assurance
The observation that closes a facility is rarely the dramatic one.
The 12-day notice: how a compounding wind-down works in Canada
The document is four pages. Three of them are about dates.
Homopeptide declines, for the 8th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
India declines to reimburse dulaglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
The quiet end of Halvard & Pike Apothecary of Portland, Maine
A proper account of an operation that existed, and of what closing it cost.
Turkey pharmacy body issues counselling standards for tirzepatide initiation
The evidence base is thin and the document says so, which is to its credit.